Vaishali Pharma gets approval, registration for five new products

31 Dec 2020 Evaluate

Vaishali Pharma has received approval and Registration for Five new products i.e. VEGAFLU, VIPRIN 75, VIPROAZ –SUSPENSION, MALPHAREX and CELLARGY from the Ministry of Health and Medicine of Turkmenistan. These products have a good demand in the local markets of Turkmenistan. This remarkable achievement in the symbolizes a landmark and enables the Company to strengthen its presence in the high growth market of Turkmenistan and enables the Company to reach out to more and more territories. The Company also plans to register the similar range of products in the neighboring Countries.

Turkmenistan Health care industry has shown one of the strongest growth rates in the Central Asia region with annual spending growth rate of around 18% and CAGR for coming five years is expected to be over 12%. Government has developed strong health care modernization plan.

Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets.

Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.